港股早評:三大指數低開 科技股、汽車股普跌 泡泡瑪特再創新高
特朗普單邊關稅言論及美國CPI令美元承壓,隔夜美股三大指數高開低走集體收跌,熱門中概股漲跌不一。港股三大指數集體低開,恆指跌0.59%,國指跌0.78%,恆生科技指數跌1.13%。盤面上,大型科技股普遍下跌,阿里巴巴跌2.28%,美團、京東跌近2%,小米跌超1%,百度跌0.92%;汽車股全線下跌,新能源車“蔚小理”跌幅居前,創新藥概念股繼續昨日回調行情,博安生物、康方生物跌超2%,航空股、互聯網醫療股、風電股普跌,半導體龍頭中芯國際跌1.56%。另一方面,特朗普單邊關稅言論及美國CPI令美元承壓,黃金價格繼續攀高,黃金股集體上漲,新消費概念股繼續活躍,泡泡瑪特再創新高,老鋪黃金漲近2%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.